We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Proteasome Blocker Brings Glaucoma Gene Therapy Closer

News   Jan 17, 2018 | Original Story from the University of Wisconsin-Madison

 
Proteasome Blocker Brings Glaucoma Gene Therapy Closer

To improve gene transfer to treat the blinding disease glaucoma, the front of an untreated eye (left) is compared to an eye (right) pre-treated with a gene delivery enhancer. The green marker reveals the expression of the gene introduced through gene therapy, showing improved delivery using the enhancer. Credit: Curtis Brandt/Paul Kaufman, University of Wisconsin-Madison

 
 
 

RELATED ARTICLES

Test Which Identifies Drug-resistant Tuberculosis Bacteria Now Available In Europe

News

Now available in Europe: A diagnostic test which can simultaneously detect tuberculosis-causing bacteria and determine if the bacteria contain mutations associated with resistance to two important first line drugs.

READ MORE

A Dog's Color Could Impact Life Expectancy

News

New research led by the University of Sydney has revealed the life expectancy of chocolate Labradors is significantly lower than their black and yellow counterparts.

READ MORE

Functioning 3D Human Neural Networks Developed From Stem Cells

News

This 3D neuro-model could help uncover early stage biomarkers of disease, in turn supporting earlier diagnosis and improving understanding of disease progression.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE